5AM part­ners set a wake­up call for biotech Fund VI, shoot­ing for a record $350M

The num­bers keep on get­ting big­ger in biotech in­vest­ing, and 5AM Ven­tures isn’t about to buck that trend.

It’s time for the busy VC to raise Fund VI, and 5AM has jot­ted down $350 mil­lion for the tar­get in an SEC fil­ing — though they would like­ly be will­ing to take more.

That fig­ure po­si­tions the VC at a new high wa­ter mark, fol­low­ing a $285 mil­lion Fund V in the spring of 2016 and the $250 mil­lion Fund IV from 2013. It takes about 30 months for 5AM to run through a fund, and there’s no rea­son to think that this one will be any dif­fer­ent.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER